MannKind Corp (NASDAQ:MNKD)
Industry: Healthcare

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The company was founded in 1991 and is headquartered in Westlake Village, California.

Current Quote*
Last: $3.070
Change: 0.010
Book: $Unk
Volume: 3,303,438

As Of: 02/23 17:19 ET
*Quotes delayed by 20min.

Graphs for MNKD


3 Month Graph


6 Month Graph


1 Year Graph